Outcomes Impacting Quality of Life in Advanced Parkinson’s Disease Patients Treated with Levodopa-Carbidopa Intestinal Gel

por Kovács, Norbert, Bergmann, Lars, Anca-Herschkovitsch, Marieta, Cubo, Esther, Davis, Thomas L., Iansek, Robert, Siddiqui, Mustafa S., Simu, Mihaela, Standaert, David G., Chaudhuri, K. Ray, Bourgeois, Paul, Gao, Tianming, Kukreja, Pavnit, Pontieri, Francesco E., Aldred, Jason
Publicado 2022

DUOGLOBE: One‐Year Outcomes in a Real‐World Study of Levodopa Carbidopa Intestinal Gel for Parkinson's Disease

por Standaert, David G., Aldred, Jason, Anca‐Herschkovitsch, Marieta, Bourgeois, Paul, Cubo, Esther, Davis, Thomas L., Iansek, Robert, Kovács, Norbert, Pontieri, Francesco E., Siddiqui, Mustafa S., Simu, Mihaela, Bergmann, Lars, Kukreja, Pavnit, Robieson, Weining Z., Chaudhuri, K. Ray
Publicado 2021

Levodopa Carbidopa Intestinal Gel in Advanced Parkinson’s Disease: DUOGLOBE Final 3-Year Results

por Chaudhuri, K. Ray, Kovács, Norbert, Pontieri, Francesco E., Aldred, Jason, Bourgeois, Paul, Davis, Thomas L., Cubo, Esther, Anca-Herschkovitsch, Marieta, Iansek, Robert, Siddiqui, Mustafa S., Simu, Mihaela, Bergmann, Lars, Ballina, Mayra, Kukreja, Pavnit, Ladhani, Omar, Jia, Jia, Standaert, David G.
Publicado 2023